ArdorComm Media Group

Health & Wellness Community

IRDAI Removes Age Limit for Health Insurance, Enhancing Coverage and Accessibility

News on Health

The Insurance Regulatory and Development Authority of India (IRDAI) has taken a significant step towards enhancing healthcare accessibility and coverage by eliminating the age limit of 65 years for individuals purchasing health insurance policies. This move aims to foster a more inclusive healthcare ecosystem and provide comprehensive protection against unforeseen medical expenses. Key Points: Removal of Age Limit: Previously, individuals were restricted from purchasing new health insurance policies after the age of 65. However, the recent amendment, effective from April 1, allows individuals of any age to buy new health insurance policies. Inclusive Product Offerings: IRDAI mandates insurers to offer health insurance products catering to all age groups. Insurers are encouraged to design specific products tailored for senior citizens, students, children, maternity, and other specified groups. Coverage for Pre-Existing Conditions: Insurance companies are now required to provide coverage for individuals with pre-existing medical conditions, such as cancer, heart or kidney failure, and AIDS. Denial of coverage based on pre-existing conditions is prohibited. Flexible Premium Payment: Insurers are permitted to offer premium payment options in instalments, enhancing convenience for policyholders. AYUSH Treatment Coverage: There is no limit on coverage for treatments under Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy. Such treatments will receive coverage up to the sum insured without any cap. Multiple Claims Filing: Policyholders with benefit-based policies can file multiple claims with various insurers, providing flexibility and choice. Specialised Channel for Senior Citizens: The regulation establishes a specialised channel to handle complaints and claims of senior citizens, ensuring a tailored and responsive approach to their requirements. The removal of age restrictions and the introduction of comprehensive coverage for pre-existing conditions signify a significant step towards enhancing healthcare access and protection for individuals across all age groups in India.  

IRDAI Removes Age Limit for Health Insurance, Enhancing Coverage and Accessibility Read More »

Max Health Shares Dip 4% as NSE Refuses Fine Waiver for Flouting Board Norms

News on health

Max Healthcare Institute Ltd faced a setback in its stock value as shares dipped by 4.4% to Rs 782 per share in Thursday’s intraday trading. This decline followed the National Stock Exchange’s decision not to waive off a fine amounting to Rs 2,36,000 imposed on the hospital chain. The refusal by NSE to grant the waiver came after Max Healthcare’s request for leniency regarding a fine imposed last year in November. The fine was levied for non-compliance with the board composition requirements outlined under regulation 17(1) of the SEBI Regulations, 2015. Despite this setback, Max Healthcare is continuing its growth trajectory with a significant investment plan. The company is gearing up to invest Rs 2500 crore in developing hospitals in Lucknow, with a particular focus on expanding its footprint in Uttar Pradesh. Max Healthcare had earlier acquired the 550-bed Sahara Hospital in Lucknow for Rs 940 crore, a move aimed at solidifying its position as a key player in the private healthcare sector in the state. The investment plan includes doubling the group’s capacity by adding 4,200 beds over the next four to five years, representing an investment of over Rs 5,000 crore. This expansion initiative aligns with Max Healthcare’s vision to enhance its presence and service offerings in the region. The acquisition of Sahara Hospital, now renamed Max Super Specialty Hospital, marks the beginning of Max Healthcare’s strategic expansion plans. The hospital, situated in Gomti Nagar, Lucknow, boasts 285 operational beds and occupies a 27-acre land area. Despite the recent stock price dip, Max Healthcare remains a significant player in the healthcare sector, managing 17 hospitals with over 3,500 beds and employing more than 4,800 clinicians across various locations including the Delhi National Capital Region, Mohali, Bathinda, Dehradun, and Mumbai. At 11:48 AM, Max Healthcare was trading 3.40% lower at Rs 790.20 per share. The stock has shown resilience over the past month, gaining 8.12%, and has demonstrated strong growth, rallying 36.66% over the last six months. Currently, it trades at a price-to-earnings multiple of 138.88.  

Max Health Shares Dip 4% as NSE Refuses Fine Waiver for Flouting Board Norms Read More »

Government Advisory May Impact Sales of Health Food Drinks, Including Bournvita

The recent advisory issued by the Centre to e-commerce platforms, directing them to remove the label of ‘health drinks’ from certain popular brands like Bournvita, could have a significant impact on the sales of health food drinks in India. Market experts suggest that this move might affect the broader category, which has already been experiencing a slowdown due to high input costs. The advisory, issued by the commerce and industry ministry’s department for promotion of industry and internal trade (DPIIT), highlighted the lack of standards and definition of ‘health drinks’ under India’s food laws. It follows a notice by the Food Safety and Standards Authority of India (FSSAI) earlier in April, urging e-commerce platforms to ensure appropriate categorization of products sold under the health and energy drinks category. While health food drinks in India have been marketed primarily as malt-based milk drinks offering some nutritional benefits, companies use various tags to promote their products. However, the term ‘health drink’ lacks a standardized definition under the FSSAI rules or regulations. Market experts anticipate that this advisory could lead to a temporary slowdown in the stocking of such brands, particularly in tier-I markets. However, companies may focus on expanding their presence in tier-II and rural markets to mitigate the impact. Analysts believe that while the advisory might affect sales in the short term, consumers generally purchase these products based on their preferred brands rather than the category label. Additionally, sales volumes in this category have already been sluggish due to price hikes. Overall, the move aims to address concerns related to high sugar content and misleading health claims, particularly those targeting children. It underscores the need for regulatory measures to ensure consumer safety and transparency in product labeling and marketing. Despite the potential impact on sales, companies are yet to respond to queries regarding the advisory, reflecting the evolving dynamics in the health food drinks market and the regulatory landscape.

Government Advisory May Impact Sales of Health Food Drinks, Including Bournvita Read More »

The Interconnection Between Climate Change and Immune Health: A Growing Concern

As the global community grapples with the multifaceted challenges of climate change, a concerning trend has emerged: a rise in immune-mediated diseases. From nasal allergies to rheumatoid arthritis to cancer, diseases linked to immune dysregulation are on the ascent, and climate change appears to be a contributing factor. A recent study led by Harvard T.H. Chan School of Public Health sheds light on this critical issue, highlighting the profound implications of climate-driven stressors on human health. The study, published in Frontiers in Science and co-authored by Kari Nadeau, a leading expert in climate and population studies, underscores the intricate interplay between environmental factors and immune health. Climate-driven stressors, such as wildfires, extreme weather events, and changes in agricultural practices, are triggering immune dysregulation, thereby exacerbating the prevalence of immune-mediated diseases. Nadeau’s research elucidates the mechanisms through which climate change impacts immune health. For instance, pollutants from wildfires and heightened pollen levels due to warmer temperatures can compromise the body’s defense mechanisms, leaving individuals more susceptible to infections and allergic reactions. Moreover, disruptions in food production and nutrient depletion resulting from climate-related events contribute to malnutrition, impairing immune system function and exacerbating the risk of disease. Of particular concern is the role of persistent inflammation induced by climate-related stressors in driving immune-mediated diseases, including cancer. As temperatures rise and extreme weather events become more frequent, the prevalence of chronic inflammation poses a significant public health challenge, necessitating urgent action to mitigate its impact. To address the global rise in immune-mediated diseases, Nadeau advocates for a multifaceted approach. This includes implementing policies to curb greenhouse gas emissions, promoting sustainable agricultural practices, and investing in research to better understand the complex interactions between climate change and immune health. Additionally, she underscores the importance of public awareness and education, urging scientists, clinicians, policymakers, and the media to communicate the tangible health consequences of climate change to the general public. The study by Harvard T.H. Chan School of Public Health highlights the pressing need to address the intersection of climate change and immune health. By recognizing the profound impact of environmental factors on human well-being, we can galvanize collective action to safeguard public health in the face of a changing climate. As we strive to build a more resilient and sustainable future, prioritizing the protection of immune health must remain a central tenet of our global health agenda.

The Interconnection Between Climate Change and Immune Health: A Growing Concern Read More »

Delhi Government Warns of Adverse Mental Health Effects Due to Air Pollution, NGT Seeks Action

The Delhi government has alerted the National Green Tribunal (NGT) to the detrimental impact of air pollution on mental health, highlighting feelings of sadness, cognitive difficulties, and decreased resilience among individuals. Responding to NGT’s inquiry on the psychological consequences of declining air quality, the government emphasized the urgent need to analyze mental health effects. In its submission, the Delhi government referenced studies demonstrating the adverse effects of air pollution on mental well-being, especially among rural and economically vulnerable populations. Environmental pollutants, particularly air pollutants, have been linked to various mental health issues, including anxiety, mood changes, and psychotic disorders, according to the government’s report. The NGT bench, led by Justice Prakash Shrivastava, noted the Delhi government’s recommendations for addressing mental health challenges posed by air pollution. These include general measures such as physical activity and therapy, as well as specific interventions like psychiatric services provided by government hospitals. However, the NGT expressed concern over the lack of monitoring for certain air pollutants, including ammonia, lead, nickel arsenic, and Benzo(a)pyrene. The tribunal emphasized the need for comprehensive monitoring and urged the Central Pollution Control Board (CPCB) to provide additional data on these parameters. Furthermore, the NGT raised questions regarding the disbursement of environmental compensation (EC) funds for road construction by municipal authorities. Doubting the legitimacy of such expenditures, the tribunal directed the CPCB to submit a detailed report outlining the approval process for fund allocation, the utilization plan for environmental components, and the correlation between pollutants and human health. As air pollution continues to pose significant risks to public health, the NGT’s scrutiny underscores the imperative for proactive measures to safeguard mental well-being and mitigate environmental hazards.  

Delhi Government Warns of Adverse Mental Health Effects Due to Air Pollution, NGT Seeks Action Read More »

India Emerges as Global Cancer Capital, Witnessing Alarming Surge in Cases, Reports Apollo Hospitals

A recent study by Apollo Hospitals reveals concerning trends in non-communicable diseases (NCDs) across India, with cancer cases witnessing an unprecedented rise. The 4th edition of the Health of Nation Report, released on World Health Day 2024, designates India as the “cancer capital of the world.” The report highlights a surge in NCDs such as cancer, diabetes, hypertension, cardiovascular diseases, and mental health disorders, significantly impacting the nation’s health landscape. Disturbingly, one in three Indians is pre-diabetic, two in three are pre-hypertensive, and one in 10 suffers from depression. Key Insights: Cancer cases in India have surpassed global rates, with the country experiencing a surge in diagnoses, particularly among younger demographics. Despite the lower median age for cancer diagnosis, cancer screening rates in India remain alarmingly low. Breast cancer, cervix cancer, and ovarian cancer are prevalent among women, while lung cancer, mouth cancer, and prostate cancer are common among men. Report Findings: Obesity rates have doubled from 9 percent in 2016 to 20 percent in 2023, while hypertension cases have risen from 9 percent to 13 percent during the same period. A significant proportion of Indians are at risk for obstructive sleep apnea, highlighting the need for urgent health interventions. The report underscores the critical need for regular health screenings to monitor conditions like obesity and hypertension, thereby reducing the risk of cardiac-related ailments. Dr. Preetha Reddy, Vice Chairperson of Apollo Hospitals, advocates for collective efforts to combat NCDs through education and personalised preventive healthcare solutions. Dr. Madhu Sasidhar, President & CEO of Apollo Hospitals, emphasizes the importance of innovation in preventive healthcare and improved accessibility, leveraging technology for accurate diagnosis and patient-centric treatment methodologies. The findings of the report underscore the urgent need for unified action to address the growing epidemic of NCDs in India. Prioritising investments in health infrastructure, promoting preventive healthcare measures, and addressing health inequities are crucial steps towards sustainable development in the health sector.  

India Emerges as Global Cancer Capital, Witnessing Alarming Surge in Cases, Reports Apollo Hospitals Read More »

Health Ministry Issues Guidelines Ahead of Summer Heatwave: Key Precautions

As the summer season approaches, the Ministry of Health has taken proactive steps to ensure public safety amidst rising temperatures and potential heatwaves. Here are the key precautions outlined by the Ministry following a review meeting led by Union Health Minister, Dr. Mansukh Mandaviya: Review Meeting Highlights: The Union Health Minister chaired a review meeting with stakeholders to assess preparedness in tackling heat-related illnesses. Dr. Bharati Pawar, MoS (Health), Dr. V K Paul, Member (Health) at NITI Aayog, and Shri Apurva Chandra, Secretary (Health), were among the dignitaries present. Importance of Awareness: Dr. Mansukh Mandaviya emphasized the importance of continuous efforts to generate awareness among people for better management of heatwaves. Timely and wide-reaching awareness can significantly reduce the severe impact of heatwaves. Guidelines for Heatwave Management: Dos: Stay hydrated Block direct sunlight Remain covered Stay indoors during 12 pm – 4 pm Don’ts: Avoid going out between 12 pm to 4 pm Minimize outdoor activities in the sun Avoid cooking from 2 pm to 4 pm Never leave kids and pets unattended inside a vehicle Avoid alcohol, tea, coffee, sugary drinks, and fizzy drinks Refrain from walking barefoot Additional Precautions: Monitor the health of elderly or sick individuals living alone daily. Keep homes cool using curtains, shutters, or sunshades, and open windows at night. Prefer lower floors during the day and use fans and damp clothes to cool down the body. These guidelines supplement earlier precautions provided by the Health Ministry to combat the effects of rising temperatures. By adhering to these measures, individuals can mitigate the risks associated with heat-related illnesses and ensure their well-being during the summer months.  

Health Ministry Issues Guidelines Ahead of Summer Heatwave: Key Precautions Read More »

Health Insurers React as Medicare Advantage Rates Stagnate

Health insurance stocks took a tumble as US regulators opted not to increase payments for private Medicare plans as anticipated, signaling a shift from previous years’ trends. The decision, met with surprise on Wall Street, presents a new challenge for insurers grappling with rising medical costs. The Biden administration’s adherence to proposed Medicare Advantage rates for 2025 marks a departure from historical norms, with only one instance in the past decade where final rates remained unchanged from initial proposals. The industry, already contending with mounting expenses, faces additional hurdles amid the unexpected policy stance. Humana Inc., heavily reliant on Medicare, saw a 9.4% decline in extended trading, while UnitedHealth Group Inc. and CVS Health Corp. experienced respective drops of 4.6% and 5.2%. Other major insurers like Elevance Health Inc. and Centene Corp. also registered significant declines. Although US payments to Medicare Advantage plans will increase by 3.7% on average in 2025, consistent with January’s proposal, the lack of a substantial hike poses challenges for insurers. The announcement, framed as a payment boost by the Centers for Medicare and Medicaid Services, underscores the program’s growing costs, expected to surpass half a trillion dollars. The decision casts a shadow over the health insurance industry’s growth prospects, particularly for key players like Humana, UnitedHealth, and CVS. Analysts suggest that insurers might respond by adjusting benefits or premiums, given the constrained payment environment. America’s Health Insurance Plans, an industry association, voiced concerns over the policy’s impact, especially amid broader shifts in Medicare Advantage regulations. The decision comes against a backdrop of mounting healthcare expenses, particularly notable at UnitedHealth and Humana, prompting investor apprehension. With earnings targets potentially in jeopardy and cost pressures mounting, insurers are bracing for a challenging period ahead, navigating uncertainties in a pivotal segment of the healthcare market.  

Health Insurers React as Medicare Advantage Rates Stagnate Read More »

Decline of COVID-19 Variant JN.1 as Emerging Subvariant Takes Hold

The prevalence of the dominant COVID-19 variant, JN.1, is waning as an emerging subvariant gains ground, signaling a shift in the trajectory of the pandemic. JN.1, which surged in the U.S. late last year, has seen a significant decrease in its contribution to new COVID-19 infections. Estimates from the Centers for Disease Control and Prevention indicate that JN.1 accounted for 86% of new cases over the past two weeks, down from 90% at the beginning of March. This variant, closely related to BA.2.86, had previously driven infections during the fall and winter months. Now, JN.1 is ceding ground to a subvariant, JN.1.13, which has experienced a notable increase in recent weeks. From comprising nearly 2% of new cases last month, JN.1.13 has risen to nearly 11% over the past two weeks. Additionally, another descendant, JN.1.18, has witnessed a modest uptick, albeit to a lesser extent, representing less than 2% of new infections in the same timeframe. Despite the emergence of various subvariants, overall COVID-19 transmission is declining across most regions of the U.S. While respiratory illness levels remain elevated in many areas, key indicators for the virus are on a downward trend. Weekly hospitalizations due to COVID-19 have decreased by nearly 14% in the past week, marking the first time new admissions have fallen below 10,000 since July 2023. Furthermore, recent data released by the CDC indicates a rise in life expectancy in 2022, attributed in part to a decline in COVID-19 mortality. Although this increase marks a reversal from the pandemic’s earlier impacts, it represents only a partial recovery from the losses incurred during the pandemic’s peak.

Decline of COVID-19 Variant JN.1 as Emerging Subvariant Takes Hold Read More »

Karnataka Health Minister Accuses Centre of Disrupting Anti-TB Drug Supply

Karnataka’s Health Minister, Dinesh Gundu Rao, has voiced concerns over interruptions in the supply of anti-tuberculosis (TB) drugs by the Central government. Rao highlighted the critical shortage of medications, putting the lives of over 80,000 TB patients at risk annually in the state. Expressing dismay over the lack of adequate drug quantities, Rao emphasized the detrimental impact of delayed communications and directives from the Union Government, especially during the model code of conduct period. He urged immediate action to rectify the situation, stressing that neglecting people’s health amid electoral considerations is unjustifiable. Rao’s assertions come amidst accusations of “stepmotherly treatment” towards Karnataka by the Centre regarding funding for various development projects, particularly in drought-affected regions. State Deputy Chief Minister DK Shivakumar also criticized the Centre for not providing the mandated extra 50 days of work under the MGNREGA program for drought-hit taluks, despite repeated appeals from state officials. Shivakumar underscored the urgency of addressing these issues, pointing out the legal obligation to provide additional support during times of crisis. Despite appeals to Union Ministers, including the Prime Minister and Home Minister, Shivakumar lamented the lack of financial assistance for drought relief efforts in Karnataka.

Karnataka Health Minister Accuses Centre of Disrupting Anti-TB Drug Supply Read More »